Cuorips Inc. (4894.T)
JPY 8110.0
(0.75%)
JPY 8110.0
(0.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.56 Billion JPY | -89.03% |
| 2022 | -2.94 Billion JPY | 11.97% |
| 2021 | -3.34 Billion JPY | 5.66% |
| 2020 | -3.54 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.09 Billion JPY | 8.46% |
| 2023 Q2 | -5.8 Billion JPY | -6.74% |
| 2023 FY | -5.56 Billion JPY | -89.03% |
| 2023 Q4 | -5.56 Billion JPY | 0.94% |
| 2023 Q3 | -5.61 Billion JPY | 3.28% |
| 2023 Q1 | -5.43 Billion JPY | -84.83% |
| 2022 FY | -2.94 Billion JPY | 11.97% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q4 | -2.94 Billion JPY | 0.0% |
| 2021 FY | -3.34 Billion JPY | 5.66% |
| 2020 FY | -3.54 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 848.696% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -390.413% |
| GNI Group Ltd. | -17.93 Billion JPY | 68.991% |
| Linical Co., Ltd. | -4.46 Billion JPY | -24.594% |
| Trans Genic Inc. | -221.16 Million JPY | -2414.37% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | -26.558% |
| Soiken Holdings Inc. | -4.79 Billion JPY | -16.096% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 487.922% |
| AnGes, Inc. | -3.79 Billion JPY | -46.429% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -1221.51% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 122.326% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -1016.323% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -1092.461% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -105.497% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -194.514% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -466.212% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -63.703% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -437.527% |
| Kidswell Bio Corporation | 343.58 Million JPY | 1718.506% |
| PeptiDream Inc. | 3.29 Billion JPY | 268.925% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -471.771% |
| Ribomic Inc. | -2.09 Billion JPY | -164.842% |
| SanBio Company Limited | -3.78 Billion JPY | -46.739% |
| Healios K.K. | -2.19 Billion JPY | -153.927% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -488.554% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -111.917% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -292.432% |
| StemRIM | -8.41 Billion JPY | 33.876% |
| CellSource Co., Ltd. | -4.68 Billion JPY | -18.737% |
| FunPep Company Limited | -1.79 Billion JPY | -210.086% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -160.287% |
| Stella Pharma Corporation | -1.11 Billion JPY | -396.783% |
| TMS Co., Ltd. | -3.44 Billion JPY | -61.346% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | -0.096% |
| K Pharma,Inc. | -3.26 Billion JPY | -70.248% |
| Takara Bio Inc. | -32.2 Billion JPY | 82.731% |
| ReproCELL Incorporated | -2.93 Billion JPY | -89.211% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -741.353% |
| StemCell Institute Inc. | -2.83 Billion JPY | -96.034% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -169.123% |
| CellSeed Inc. | -2.01 Billion JPY | -176.386% |